- Source and develop partnerships between our researchers and industry in the following therapeutic areas: oncology, rheumatoid arthritis, obesity, precision medicine, and AI/ML.- Identify and develop partners for our Drug Discovery Center, which has high throughput screening capabilities.

- Member of the Advisor Board and Founding Advisor.

- The team manages a portfolio valued at over $13 million.- Covered specific stocks: did company and industry research, analyzed SEC filings and relevant notes, prepared pro forma financial statements, developed financial valuation models, made EPS projections, and also evaluated comparables.- Prepared relevant reports, and made presentations to the team weekly.

- Led team through a 7 week Lean Cohort Program.- Investigated the commercial landscape surrounding specific innovations.- Tested the value proposition and who the target market segment is for a specific innovation.

• Conduct prior art searches and assess patentability of invention disclosures from a variety of disciplines.• Examine competitive market landscape and evaluate commercialization potential of inventions to prioritize patent applications to pursue.

- Prepare marketing and technology commercialization reports on different technologies to assist with due diligence on potential investments with startup companies.- Attend pitch presentations of startup companies and provide feedback.

•Providing feedback on the value proposition of a new product and the business plan.•Conduct business development and providing introductions to potential strategic partners, customers and key opinion leaders who can gave expert feedback on the technology.•Working on the design of a business model for a startup company, Alzeca Biosciences.•Alzeca is developing an innovative diagnostic/therapeutic for Alzhiemers Disease.•In order to develop the business model, talked to customers, strategic partners and key opinion leaders to gain expert feedback.

•Built and led two cross-functional graduate student teams for the NIH Startup Challenge 2014 competition along with advisors from industry, academia, and venture capital. Trained teams to use business model canvas and lean startup thinking to develop a business plan. One of the teams was named a Finalist in the competition in May 2015. •Currently building a student team with a cast of advisors for the 2015 NIH Startup Challenge and the theme is nanotechnology used in cancer therapy/diagnostics.•Educated teams on the phases in the drug development process.•Support activities by the Entrepreneurship Center and Tech Incubator.•Panelist for AIChE Midwest Regional Conference symposium on Professional Development for Entrepreneurs.•Assist the evaluation of the commercial feasibility of the technology concept described through an invention disclosure, and make recommendations on whether to proceed with patenting.•Find potential licensees and investment partners for technologies.•Work with companies that are potential licensees of an early stage technology and find ways for a funded collaboration to further develop the technology.•Liaison to industry contacts, venture capital firms and governmental organizations.•Assist in setting up non-disclosure agreements and developing inter-institutional agreements.•Develop technology marketing brochures and raise awareness of research activities at IIT.•As a panelist gave a presentation on Industry – Academia Collaborations for IIT staff and research administrators. Faculty and Corporate Relations staff were in attendance. •Gave a lecture to post-doc fellows at Argonne National Laboratory on the Lean Business Model Canvas and Customer Discovery as part of a mini-course.•Educate undergraduates, graduates, post-docs and faculty on considering what to consider when launching a startup and the steps to take in order to mitigate risk in the innovative technology.

•Developed Marketing Brochure to show site capabilities while differentiating it from other CMOs, and distributed these brochures throughout network of contacts.•Worked on a team that was tasked to improve employee motivation and also build a culture of innovation at the facility.•Managed projects, developed timelines and milestones using GANTT charts, led cross-functional matrix project team meetings, prepared meeting minutes.•Evaluated various innovative technologies and prepared a proposal for management consideration.•Implemented the use of Quality by Design (QbD) and risk management approaches to the development process based on FDA Regulatory Guidelines.•Led a team through the steps of identifying the target product profile, and conducting an assessment of the risk of the different unit operations. This led to designing studies in areas to mitigate risk in the formulation and process development.•Established internal risk management process based on FDA guidelines.•Built a team of two engineers and managed the team’s performance. Responsible to do the performance reviews for team members.•Successfully led the team that transferred and validated a major product from the Philadelphia facility to the Chicago area facility. •Assisted in authoring and reviewing development reports for the CMC sections of NDA regulatory filing. •Made proposals for consideration to evaluate new technologies.•Member of the Site Leadership team.

•Managed process development studies, scale-up projects and conducted technology transfer between facilities of controlled release multiparticulate system products.•Prepared product development reports to be included in the in the CMC section of the Regulatory Submissions.

•Assisted the department in the marketing of technical proficiencies and company capabilities.•Served a business development function by assisting marketing/sales team to work the exhibit booth at AAPS conferences. •Coordinated a proposal for a symposium at a conference. Recruited key opinion leaders from industry to be part of the symposium proposal.•Managed multiple projects.•Led the development through commercialization efforts for a major arthritis product for a virtual pharmaceutical company. •Prepared development reports for clients that were formatted into the CMC section of the NDA regulatory filings.•Worked on Quality by Design through Design of Experiments to develop formulations to meet target the target product profile. •Play a role as consultant for client companies and give recommendations on aspects of product development.

•Successfully transferred a major urology product to a contract manufacturing facility.•Provided oversight and management of a technology transfer and scale-up of a wurster coating process to a contract manufacturing facility.•Wrote development reports to be incorporated in the CMC section of NDA filings.